Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Galbiati

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|August 28, 1999
Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complexF Galbiati, D Volonte, C Minetti, et al.
The Journal of Biological Chemistry|September 7, 2000
Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3F Galbiati, D Volonte, C Minetti, et al.
Neurology|February 26, 2004
Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseasesS E Woodman, F Sotgia, F Galbiati, et al.
American Journal of Physiology. Cell Physiology|March 14, 2001
Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulationJ Liu, P Lee, F Galbiati, et al.
FEBS Letters|December 9, 1998
Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cellsC P Yang, F Galbiati, D Volonte, et al.
The Urologic Clinics of North America|October 29, 2022
Benefits and Risks of Testosterone Treatment of Older Men with HypogonadismFrancesca F Galbiati, Anna L Goldman, Arijeet Gattu, et al.
The Journal of Biological Chemistry|April 23, 1999
Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probeD Volonte, F Galbiati, S Li, et al.
The Journal of Biological Chemistry|October 9, 1999
Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formationF Galbiati, D Volonte, J A Engelman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 8, 2008
Phenotype and function of dendritic cells and T-lymphocyte polarization in the human colonic mucosa and adenocarcinomaL Gianotti, M Sargenti, F Galbiati, et al.
Reumatismo|February 4, 2003
[Case report: rheumatoid arthritis and large granular lymphocytes syndrome]F Ingegnoli, M Arreghini, B Panni, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|August 28, 1999
Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complexF Galbiati, D Volonte, C Minetti, et al.
The Journal of Biological Chemistry|September 7, 2000
Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3F Galbiati, D Volonte, C Minetti, et al.
Neurology|February 26, 2004
Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseasesS E Woodman, F Sotgia, F Galbiati, et al.
American Journal of Physiology. Cell Physiology|March 14, 2001
Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulationJ Liu, P Lee, F Galbiati, et al.
FEBS Letters|December 9, 1998
Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cellsC P Yang, F Galbiati, D Volonte, et al.
The Urologic Clinics of North America|October 29, 2022
Benefits and Risks of Testosterone Treatment of Older Men with HypogonadismFrancesca F Galbiati, Anna L Goldman, Arijeet Gattu, et al.
The Journal of Biological Chemistry|April 23, 1999
Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probeD Volonte, F Galbiati, S Li, et al.
The Journal of Biological Chemistry|October 9, 1999
Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formationF Galbiati, D Volonte, J A Engelman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 8, 2008
Phenotype and function of dendritic cells and T-lymphocyte polarization in the human colonic mucosa and adenocarcinomaL Gianotti, M Sargenti, F Galbiati, et al.
Reumatismo|February 4, 2003
[Case report: rheumatoid arthritis and large granular lymphocytes syndrome]F Ingegnoli, M Arreghini, B Panni, et al.
Pageof 8